The Motley Fool··Motley Fool TranscribingTenon Medical Doubles Q4 Revenue on FDA Clearance, Eyes Aggressive 2026 Expansion
Tenon Medical reports 92% Q4 revenue growth to $1.5M, achieves 69% gross margins, secures FDA clearance and $4.3M financing for spine fusion device expansion.
TNONTNONWrevenue growthfinancing